Anika Therapeutics, Inc. Gain (Loss) on Investments
Anika Therapeutics, Inc. (ANIK) reported Gain (Loss) on Investments of -$13.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-26.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2021-04-26
- Anika Therapeutics, Inc. gain (loss) on investments for the quarter ending 2020-12-31 was -$10.00K.
- Anika Therapeutics, Inc. gain (loss) on investments for the quarter ending 2020-09-30 was -$3.00K, a 100.94% decline year-over-year.
- Anika Therapeutics, Inc. gain (loss) on investments for the quarter ending 2019-12-31 was -$1.05M.
- Anika Therapeutics, Inc. gain (loss) on investments for the quarter ending 2019-09-30 was $318.00K.
- Anika Therapeutics, Inc. gain (loss) on investments for fiscal 2020 was -$13.00K, a 152.00% decline from fiscal 2019.
- Anika Therapeutics, Inc. gain (loss) on investments for fiscal 2019 was $25.00K, a 93.26% decline from fiscal 2018.
- Anika Therapeutics, Inc. gain (loss) on investments for fiscal 2018 was $371.00K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$10.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | -$13.00K derived: sum of 2 quarters · filed 2021-04-26 | -$13.00K 10-K/A · filed 2021-04-26 | |
| 2020-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$3.00K 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | |||
| 2019-12-31 | -$1.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | -$732.00K derived: sum of 2 quarters · filed 2021-04-26 | -$338.00K derived: sum of 3 quarters · filed 2021-04-26 | $25.00K 10-K/A · filed 2021-04-26 |
| 2019-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $712.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.07M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $757.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $363.00K 10-Q · filed 2020-05-22 | |||
| 2018-12-31 | $371.00K 10-K/A · filed 2021-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |